Navidea Updates Clinical Development Plan for Diagnostic Use of Lymphoseek® IV in Rheumatoid Arthritis Apr 4, 2016
Navidea Biopharmaceuticals to Announce Fourth Quarter and Full Year 2015 Results on March 23, 2016 Mar 21, 2016
Navidea and Platinum Enter Into Agreement Reaffirming Loan Obligations and Agreeing to Standstill Provisions Mar 14, 2016
Immunotherapeutic Potential of Manocept™ Platform Reviewed in the Journal Nuclear Medicine and Biology Mar 10, 2016
Navidea Biopharmaceuticals Enrolls First Patient in Cervical Cancer Study of Lymphoseek® Feb 11, 2016
